An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Clinical trial NCT03510715 · COMPLETED
Trial details
- NCT number
- NCT03510715
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-31
- Primary completion
- 2020-02-17
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.